SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fredrik Agholme, Brandon Macias, Matt Hamang, Jonathan Lucchesi, Mary D. Adrian, Stuart Kuhstoss, Anita Harvey, Masahiko Sato, Per Aspenberg, Efficacy of a sclerostin antibody compared to a low dose of PTH on metaphyseal bone healing, Journal of Orthopaedic Research, 2014, 32, 3
  2. 2
    Olof Sandberg, Brandon R. Macias, Per Aspenberg, Low dose PTH improves metaphyseal bone healing more when muscles are paralyzed, Bone, 2014, 63, 15

    CrossRef

  3. 3
    N Ersan, L J van Ruijven, A L J J Bronckers, V Olgaç, D İlgüy, V Everts, Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model, Dentomaxillofacial Radiology, 2014, 43, 1, 20130144

    CrossRef

  4. 4
    Aline G Costa, John P Bilezikian, E Michael Lewiecki, Update on romosozumab: a humanized monoclonal antibody to sclerostin, Expert Opinion on Biological Therapy, 2014, 14, 5, 697

    CrossRef

  5. 5
    Liana Linhares Lima, Joao Batista César Neto, Ezymar Gomes Cayana, Francisco Humberto Nociti, Enilson Antônio Sallum, Márcio Zaffalon Casati, Parathyroid hormone (1-34) compensates the negative effect of smoking around implants, Clinical Oral Implants Research, 2013, 24, 9
  6. 6
    Stephen Y. Kang, Sagar S. Deshpande, Alexis Donneys, Jose J. Rodriguez, Noah S. Nelson, Peter A. Felice, Douglas B. Chepeha, Steven R. Buchman, Parathyroid hormone reverses radiation induced hypovascularity in a murine model of distraction osteogenesis, Bone, 2013, 56, 1, 9

    CrossRef

  7. 7
    Abhishek Chandra, Shenghui Lan, Ji Zhu, Tiao Lin, Xianrong Zhang, Valerie A. Siclari, Allison R. Altman, Keith A. Cengel, X. Sherry Liu, Ling Qin, PTH prevents the adverse effects of focal radiation on bone architecture in young rats, Bone, 2013, 55, 2, 449

    CrossRef

  8. 8
    J.-M. Kaufman, J.-Y. Reginster, S. Boonen, M.L. Brandi, C. Cooper, W. Dere, J.-P. Devogelaer, A. Diez-Perez, J.A. Kanis, E. McCloskey, B. Mitlak, E. Orwoll, J.D. Ringe, G. Weryha, R. Rizzoli, Treatment of osteoporosis in men, Bone, 2013, 53, 1, 134

    CrossRef

  9. 9
    Aline Costa, Natalie E. Cusano, Barbara C. Silva, John P. Bilezikian, Osteoporosis, 2013,

    CrossRef

  10. 10
    Sung-Hsiung Chen, Shun-Chen Huang, Chun-Chung Lui, Tzu-Ping Lin, Fong-Fu Chou, Jih-Yang Ko, Effect of TheraCyte-encapsulated parathyroid cells on lumbar fusion in a rat model, European Spine Journal, 2012, 21, 9, 1734

    CrossRef

  11. 11
    P Aggarwal, A Zavras, Parathyroid hormone and its effects on dental tissues, Oral Diseases, 2012, 18, 1
  12. 12
    Cristiana Capriani, Dinaz Irani, John P Bilezikian, Safety of osteoanabolic therapy: A decade of experience, Journal of Bone and Mineral Research, 2012, 27, 12
  13. 13
    Henrik Daugaard, Brian Elmengaard, Troels Torp Andreassen, Anders Lamberg, Joan Elisabeth Bechtold, Kjeld Soballe, Systemic intermittent parathyroid hormone treatment improves osseointegration of press-fit inserted implants in cancellous bone, Acta Orthopaedica, 2012, 83, 4, 411

    CrossRef

  14. 14
    Lluis Pérez Edo, Alberto Alonso Ruiz, Daniel Roig Vilaseca, Alberto García Vadillo, Nuria Guañabens Gay, Pilar Peris, Antonio Torrijos Eslava, Chesús Beltrán Audera, Jordi Fiter Aresté, Luis Arboleya Rodríguez, Jenaro Graña Gil, Jordi Carbonell Abelló, Joan Miquel Nolla, Susana Holgado Pérez, Esteban Salas Heredia, Jaime Zubieta Tabernero, Javier Del Pino Montes, Josep Blanch i. Rubió, Manuel Caamaño Freire, Manuel Rodríguez Pérez, Santos Castañeda, Dacia Cerdá, Carmen Gómez Vaquero, Javier Calvo Catalá, Manel Ciria, Estíbaliz Loza, 2011 Up-Date of the Consensus Statement of the Spanish Society of Rheumatology on Osteoporosis, Reumatología Clínica (English Edition), 2011, 7, 6, 357

    CrossRef

  15. 15
    Lluís Pérez Edo, Alberto Alonso Ruiz, Daniel Roig Vilaseca, Alberto García Vadillo, Nuria Guañabens Gay, Pilar Peris, Antonio Torrijos Eslava, Chesús Beltrán Audera, Jordi Fiter Aresté, Luis Arboleya Rodríguez, Jenaro Graña Gil, Jordi Carbonell Abelló, Joan Miquel Nolla, Susana Holgado Pérez, Esteban Salas Heredia, Jaime Zubieta Tabernero, Javier Del Pino Montes, Josep Blanch i Rubió, Manuel Caamaño Freire, Manuel Rodríguez Pérez, Santos Castañeda, Dacia Cerdá, Carmen Gómez Vaquero, Javier Calvo Catalá, Manel Ciria, Estíbaliz Loza, Actualización 2011 del consenso Sociedad Española de Reumatología de osteoporosis, Reumatología Clínica, 2011, 7, 6, 357

    CrossRef

  16. 16
    Y.H. Ng, P.D. Gino, K. Lingaraj, S. Das De, Femoral shaft fractures in the elderly – Role of prior bisphosphonate therapy, Injury, 2011, 42, 7, 702

    CrossRef

  17. 17
    Marius E. Kraenzlin, Christian Meier, Parathyroid hormone analogues in the treatment of osteoporosis, Nature Reviews Endocrinology, 2011, 7, 11, 647

    CrossRef

  18. 18
    Henrik Daugaard, Brian Elmengaard, Troels Andreassen, Joan Bechtold, Anders Lamberg, Kjeld Soballe, Parathyroid Hormone Treatment Increases Fixation of Orthopedic Implants with Gap Healing: A Biomechanical and Histomorphometric Canine Study of Porous Coated Titanium Alloy Implants in Cancellous Bone, Calcified Tissue International, 2011, 88, 4, 294

    CrossRef

  19. 19
    Sunday A. Shoyele, Neeraj Sivadas, Sally-Ann Cryan, The Effects of Excipients and Particle Engineering on the Biophysical Stability and Aerosol Performance of Parathyroid Hormone (1-34) Prepared as a Dry Powder for Inhalation, AAPS PharmSciTech, 2011, 12, 1, 304

    CrossRef

  20. 20
    Chad L. Deal, Abby G. Abelson, Rheumatology, 2011,

    CrossRef

  21. 21
    Ángel Oteo-Álvaro, Enrique Moreno, Atrophyc humeral shaft nonunion treated with teriparatide (rh PTH 1-34): A case report, Journal of Shoulder and Elbow Surgery, 2010, 19, 7, e22

    CrossRef

  22. 22
    Paul T. Rubery, Susan V. Bukata, Teriparatide May Accelerate Healing in Delayed Unions of Type III Odontoid Fractures, Journal of Spinal Disorders & Techniques, 2010, 23, 2, 151

    CrossRef

  23. 23
    Meyler's Side Effects of Drugs in Cancer and Immunology, 2010,

    CrossRef

  24. 24
    Elizabeth File, Chad Deal, Clinical update on teriparatide, Current Rheumatology Reports, 2009, 11, 3, 169

    CrossRef

  25. 25
    Padhraig F. O’Loughlin, Matthew E. Cunningham, Susan V. Bukata, Emre Tomin, Ashley R. Poynton, Stephen B. Doty, Andrew A. Sama, Joseph M. Lane, Parathyroid Hormone (1-34) Augments Spinal Fusion, Fusion Mass Volume, and Fusion Mass Quality in a Rabbit Spinal Fusion Model, Spine, 2009, 34, 2, 121

    CrossRef

  26. 26
    Hirotoshi Yamane, Akinori Sakai, Toshiharu Mori, Shinya Tanaka, Kuniaki Moridera, Toshitaka Nakamura, The anabolic action of intermittent PTH in combination with cathepsin K Inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice, Bone, 2009, 44, 6, 1055

    CrossRef

  27. 27
    Barbara M Obermayer-Pietsch, Fernando Marin, Eugene V McCloskey, Peyman Hadji, Jordi Farrerons, Steven Boonen, Maurice Audran, Clare Barker, Athanasios D Anastasilakis, William D Fraser, Thomas Nickelsen, Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment, Journal of Bone and Mineral Research, 2008, 23, 10
  28. 28
    John L Vahle, Ulrich Zuehlke, Allen Schmidt, Michael Westmore, Peiqi Chen, Masahiko Sato, Lack of Bone Neoplasms and Persistence of Bone Efficacy in Cynomolgus Macaques After Long-Term Treatment With Teriparatide [rhPTH(1-34)], Journal of Bone and Mineral Research, 2008, 23, 12
  29. 29
    Armen H Tashjian, David Goltzman, On the Interpretation of Rat Carcinogenicity Studies for Human PTH(1-34) and Human PTH(1-84), Journal of Bone and Mineral Research, 2008, 23, 6
  30. 30
    David A. Hanley, Patricia H. Watson, Anthony B. Hodsman, David W. Dempster, Principles of Bone Biology, 2008,

    CrossRef

  31. 31
    Eleftherios Tsiridis, Elise F. Morgan, Jared M. Bancroft, Mike Song, Michael Kain, Louis Gerstenfeld, Thomas A. Einhorn, Mary L. Bouxsein, Paul Tornetta, Effects of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing, Journal of Orthopaedic Research, 2007, 25, 9
  32. 32
    Byron Chalidis, Christopher Tzioupis, Eleftherios Tsiridis, Peter V Giannoudis, Enhancement of fracture healing with parathyroid hormone: preclinical studies and potential clinical applications, Expert Opinion on Investigational Drugs, 2007, 16, 4, 441

    CrossRef

  33. 33
    Kristine D Harper, John H Krege, Robert Marcus, Bruce H Mitlak, Osteosarcoma and Teriparatide?, Journal of Bone and Mineral Research, 2007, 22, 2
  34. 34
    Fergus S.J. Keating, John C. Stevenson, Treatment of the Postmenopausal Woman, 2007,

    CrossRef

  35. 35
    Monica Girotra, Mishaela R Rubin, John P Bilezikian, Anabolic Agents for Osteoporosis, Treatments in Endocrinology, 2006, 5, 6, 347

    CrossRef

  36. 36
    John P. Bilezikian, Mishaela R. Rubin, Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis, Current Osteoporosis Reports, 2006, 4, 1, 5

    CrossRef

  37. 37
    Kristine D. Harper, John H. Krege, Robert Marcus, Bruce H. Mitlak, Comments on Initial experience with teriparatide in the United States, Current Medical Research and Opinion, 2006, 22, 10, 1927

    CrossRef

  38. 38
    John A. Robinson, Vedrana Susulic, Yao-Bin Liu, Chanda Taylor, Jill Hardenburg, Virginia Gironda, Weiguang Zhao, Yogendra Kharode, Sean McLarney, Yuchen Bai, Daniel P. Malone, Richard Murrills, Fred Bex, Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation, Journal of Cellular Biochemistry, 2006, 98, 5
  39. 39
    Deborah T. Gold, Barbara S. Pantos, Daniel N. Masica, Derek A. Misurski, Robert Marcus, Initial experience with teriparatide in the United States*, Current Medical Research and Opinion, 2006, 22, 4, 703

    CrossRef

  40. 40
    Armen H Tashjian, Robert F Gagel, Teriparatide [Human PTH(1-34)]: 2.5 Years of Experience on the Use and Safety of the Drug for the Treatment of Osteoporosis, Journal of Bone and Mineral Research, 2006, 21, 3
  41. 41
    F.-F Chou, S.-C. Huang, S.-S. Chen, P.-W. Wang, P.-H. Huang, K.-Y. Lu, Treatment of osteoporosis with TheraCyte-encapsulated parathyroid cells: a study in a rat model, Osteoporosis International, 2006, 17, 6, 936

    CrossRef

  42. 42
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  43. 43
    John P. Bilezikian, Mishaela R. Rubin, Dynamics of Bone and Cartilage Metabolism, 2006,

    CrossRef

  44. 44
    Terrence H Diamond, Pharmacotherapy of osteoporosis in men, Expert Opinion on Pharmacotherapy, 2005, 6, 1, 45

    CrossRef

  45. 45
    Stephen Hough, Brynne Ascott-Evans, Tobie de Villiers, Jan de Weerd, Graham Ellis, Stan Lipschitz, Position paper of the National Osteoporosis Foundation of South Africa (NOFSA) on the use of parathyroid hormone (PTH 1–34) in the treatment of osteoporosis, Journal of Endocrinology, Metabolism and Diabetes of South Africa, 2005, 10, 2, 51

    CrossRef

  46. 46
    Camilo Jimenez, Ying Yang, Hyung-Woo Kim, Fozia Al-Sagier, Donald A Berry, Adel K. El-Naggar, Shreyaskumar Patel, Rena Vassilopoulou-Sellin, Robert F Gagel, Primary Hyperparathyroidism and Osteosarcoma: Examination of a Large Cohort Identifies Three Cases of Fibroblastic Osteosarcoma, Journal of Bone and Mineral Research, 2005, 20, 9
  47. 47
    J. Compston, Recombinant Parathyroid Hormone in the Management of Osteoporosis, Calcified Tissue International, 2005, 77, 2, 65

    CrossRef

  48. 48
    Ki-Hyun Baek, Sequential and Combination Therapy using Parathyroid Hormone for Osteoporosis, Journal of Korean Society of Endocrinology, 2005, 20, 4, 319

    CrossRef

  49. 49
    Richard Prince, Adrien Sipos, Anwar Hossain, Unni Syversen, Sophia Ish-Shalom, Ewa Marcinowska, Johan Halse, Robert Lindsay, Gail P Dalsky, Bruce H Mitlak, Sustained Nonvertebral Fragility Fracture Risk Reduction After Discontinuation of Teriparatide Treatment, Journal of Bone and Mineral Research, 2005, 20, 9
  50. 50
    Harald Dobnig, A review of teriparatide and its clinical efficacy in the treatment of osteoporosis, Expert Opinion on Pharmacotherapy, 2004, 5, 5, 1153

    CrossRef

  51. 51
    J.M. Quesada, Agentes anabólicos óseos para el tratamiento de osteoporosis, Endocrinología y Nutrición, 2004, 51, 9, 512

    CrossRef

  52. 52
    Ajay Bhatia, Stephen Cannon, Tim Briggs, Richard W Keen, Chondrosarcoma in Association With Primary Hyperparathyroidism, Journal of Bone and Mineral Research, 2004, 19, 7
  53. 53
    C. P. Jerome, Hormonal Therapies and Osteoporosis, ILAR Journal, 2004, 45, 2, 170

    CrossRef

  54. 54
    Michael McClung, Parathyroid Hormone for the Treatment of Osteoporosis, Obstetrical & Gynecological Survey, 2004, 59, 12, 826

    CrossRef

  55. 55
    Shinya Tanaka, Akinori Sakai, Masahiro Tanaka, Hajime Otomo, Nobukazu Okimoto, Takeshi Sakata, Toshitaka Nakamura, Skeletal Unloading Alleviates the Anabolic Action of Intermittent PTH(1–34) in Mouse Tibia in Association With Inhibition of PTH-Induced Increase in c-fos mRNA in Bone Marrow Cells, Journal of Bone and Mineral Research, 2004, 19, 11
  56. 56
    Kim T. Brixen, Brixen Christensen, Charlotte Ejersted, Bente Lomholt Langdahl, Teriparatide (Biosynthetic Human Parathyroid Hormone 1–34): A New Paradigm in the Treatment of Osteoporosis, Basic & Clinical Pharmacology & Toxicology, 2004, 94, 6
  57. 57
    Elaena Quattrocchi, Helen Kourlas, Teriparatide: A review, Clinical Therapeutics, 2004, 26, 6, 841

    CrossRef

  58. 58
    P. Coates, 2004,

    CrossRef

  59. 59
    Mishaela R. Rubin, John P. Bilezikian, Principles of Gender-Specific Medicine, 2004,

    CrossRef

  60. 60
    Current Awareness: Pharmacoepidemiology and Drug Safety, Pharmacoepidemiology and Drug Safety, 2003, 12, 1
  61. 61
    Maurice Audran, Paola Insalaco, L’hormone parathyroïdienne dans le traitement de l’ostéoporose, Revue du Rhumatisme, 2003, 70, 9, 691

    CrossRef

  62. 62
    Maurice Audran, Paolo Insalaco, Parathyroid hormone therapy for osteoporosis, Joint Bone Spine, 2003, 70, 5, 315

    CrossRef

  63. 63
    Mishaela R Rubin, John P Bilezikian, The anabolic effects of parathyroid hormone therapy, Clinics in Geriatric Medicine, 2003, 19, 2, 415

    CrossRef

  64. 64
    ES Orwoll, WH Scheele, S Paul, S Adami, U Syversen, A Diez-Perez, J-M Kaufman, AD Clancy, GA Gaich, The Effect of Teriparatide [Human Parathyroid Hormone (1–34)] Therapy on Bone Density in Men With Osteoporosis, Journal of Bone and Mineral Research, 2003, 18, 1
  65. 65
    Robert Marcus, Ouhong Wang, Julie Satterwhite, Bruce Mitlak, The Skeletal Response to Teriparatide Is Largely Independent of Age, Initial Bone Mineral Density, and Prevalent Vertebral Fractures in Postmenopausal Women With Osteoporosis, Journal of Bone and Mineral Research, 2003, 18, 1